Back to Results
First PageMeta Content
American Association for Cancer Research / Protein kinase inhibitor / Display board / Academia / Poster session / Serine/threonine-specific protein kinase


SuperGen PIM Kinase Presentations at AACR DUBLIN, Calif., Mar 31, 2011 (BUSINESS WIRE) -SuperGen, Inc. (Nasdaq:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today a
Add to Reading List

Open Document

File Size: 11,88 KB

Share Result on Facebook

City

Orlando / /

Company

SuperGen Inc. / /

/

IndustryTerm

cancer therapeutics / pharmaceutical / cancer therapies / /

MedicalCondition

rapamycin-mediated tumor / ATP-binding cassette multidrug resistance protein breast cancer / novel cancer / /

MedicalTreatment

cancer therapies / cancer therapeutics / /

Organization

Poster Board / American Association for Cancer Research / /

Person

Susanna Chau / Timothy L. Enns / /

/

Position

Manager Investor Relations schau@supergen.com / Senior Vice President Corporate Communications & Business Development tenns@supergen.com / /

ProvinceOrState

Florida / California / /

PublishedMedium

Cancer Research / /

Technology

cell signaling / /

URL

www.supergen.com / http /

SocialTag